Sponsor study identifier
observational
550
1 country
1
Study Start
September 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedHigh risk population: Screening for impaired glucose tolerance.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 24, 2011
Actual (reported)July 26, 2011
Actual (reported)September 2011
Date type not reportedThis date has not been verified as actual or estimated.
Percent of patients with Diabetes Mellitus or impaired glucose tolerance
Day 1 of study
Prevalence of hypertension and hyperlipidemia
Day 1 of study
Ethiopian immigrants to Israel living in Hadera.
Diabetes and Endocrinology Unit, Hillel Yaffe MC, POB169
Hadera, 38100, Israel
First Submitted
July 24, 2011
First Posted
July 26, 2011
Study Start
September 2011
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
July 26, 2011
Record last verified: 2011-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Assessing the Reliability of Non-invasive Blood Glucose Monitoring Device
Contact the study team to confirm eligibility.